AIDSmeds.com - Top Stories

POZ.com | POZ Mentor
POZ Personals

Back to home » Treatment News » Top Stories

February 14, 2006

SMART and Treatment Interruptions: The Results Are In
On January 18th, the National Institute of Allergy and Infectious Diseases announced that enrollment into a large international clinical trial comparing continuous anti-HIV therapy with episodic drug treatment guided by T-cell counts had been stopped.

February 06, 2006

Preventing HIV Transmission with Tenofovir + Emtricitabine
In recent years, there has been a lot of attention placed on the use of Viread® (tenofovir) for pre-exposure prophylaxis (PREP) against HIV infection.

Investigating Reports of Excessive False-Positive Oral Fluid Rapid HIV Tests
Over the past several months, there have been numerous mainstream media reports regarding an unusually high number of false-positive HIV-antibody test results using the oral-based OraQuick rapid assay (the reliability of the blood-based OraQuick assay hasn't been disputed).

Trends in HIV Diagnosis among Non-Hispanic Blacks
Although HIV diagnoses have declined among most HIV risk groups, non-Hispanic blacks continue to be disproportionately affected, according to new data presented at the 13th Conference on Retroviruses and Opportunistic Infections by Dr. Tonji Durant and her colleagues at the U.S. Centers for Disease Control and Prevention.